| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-09 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-06 |